percutaneous transhepatic choledochoscopy
Procedurepercutaneous transhepatic choledochoscopy
Other names: extracorporeal shock wave lithotripsy (ESWL)
NCT Number: NCT04308993
Patients with complex biliary stone disease are challenging to treat. The investigator present their experience in using urological interventions to treat challenging biliary stones.
Methods:
Fifteen patients with biliary calculi underwent 21 interventions using either extracorporeal shock wave lithotripsy (ESWL), percutaneous transhepatic choledochoscopy, percutaneous transcystic choledochoscopy, or a combination of these.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The investigator conducted a retrospective review to investigate the outcomes of urological treatments for biliary calculi from January 1, 1999, to August 31, 2016, focusing on percutaneous endoscopic methods and/or ESWL. The primary outcomes of interest were symptom- and stone-free rates, length of hospital stay, and complications. Our institutional ethics review board approved the study (IRB-2018-01-119). Due to the retrospective nature of the study, the need for informed consent was waived. One endourologist evaluated all patients preoperatively.
Urological intervention techniques The three different approaches used (ESWL, PTHC, and PTCC) are described below.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
percutaneous transhepatic choledochoscopy
Other names: extracorporeal shock wave lithotripsy (ESWL)
Time frame: at least one year follow up
success rate of biliary stone clearance or asymptomatic derbies
Time frame: one month
evidence of stone clearance
Time frame: one day
biochemical evidence (Liver function test) of improvement
Imam Abdulrahman Bin Faisal University
Other
Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease: Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03421340
Bile Duct Diseases, Biliary Stones
Stanford, California, United States
View Trial DetailsNCT06340594
Bile Duct Diseases, Biliary Stones
Asyut, Asyut Governorate, Egypt
View Trial DetailsNCT03118973
Biliary Obstruction, Biliary Stones
Stanford, California, United States
View Trial DetailsNCT05210322
Adenocarcinoma, Bile Duct Diseases
Baltimore, Maryland, United States
View Trial Details